News

“That's how you get to see.” This was the motto of Prof Jean-Martin Charcot. In 1868, he was the first to define multiple sclerosis (MS).

Is the location of the lesions important or is it rather their number? Can the MRI result indicate when to change treatment? Dr. Solène Dauby gives the answers.

The Charcot TEAM was fantastic again and the action is not over yet. Support the Charcot Foundation team. You will support research in multiple sclerosis. 13,500 patients will be grateful to you.

7 pertinent questions you might have concerning the vaccination against COVID-19 and your MS treatment. Prof. Dr C. Sindic provides the answers...

Until now, all research has been aimed at curbing the disease. Recent research results point to a whole new future in which it will be possible to repair damaged nerve endings.

Our mission: to promote MS research and raise awareness among patients, physicians and neurologists, objectively informing them about research advances and new research avenues.

Every day counts. we need your help to make concrete progress in research into multiple sclerosis possible. Yes, I will finance one day of research.

Is a vaccine for MS a possibility in the futur? A pertinent question. Prof C. Sindic provides a hopeful answer.

Are MS patients more affected by Covid-19? Are MS patients given priority in the vaccination plan?

In 2020, Belgians donated over half a million euros to multiple-sclerosis research, which will be paid out in January 2021 by the Belgian Charcot Foundation to ten university teams.

We are closing a very special year. Just like us, you are surely longing for a new beginning, a world where people can find each other again. Let us remain optimistic and united. We wish you all the best for 2021!

The Belgian Charcot Foundation adheres to the guidelines of our health authorities, which are updated when necessary.